Destiny Pharma PLC Posting of Annual Report and Notice of AGM (4909L)
April 23 2018 - 2:00AM
UK Regulatory
TIDMDEST
RNS Number : 4909L
Destiny Pharma PLC
23 April 2018
Destiny Pharma plc
("Destiny Pharma" or "the Company")
Posting of Annual Report and Accounts, and Notice of AGM
Brighton, United Kingdom - 23 April 2018 - Destiny Pharma (AIM:
DEST), a clinical stage biotechnology company focused on the
development of novel anti-microbial drugs, which address the global
problem of anti-microbial resistance (AMR), announces that the
annual report and accounts of the Company for the year ended 31
December 2017 ("Annual Report"), and the notice of the Company's
Annual General Meeting ("AGM") are now available on the Company's
website at www.destinypharma.com
The Annual Report will be posted to shareholders today.
The AGM is to be held at 10.00am on 31 May 2018 at the offices
of FTI Consulting LLP at 200 Aldersgate, London EC1A 4HD.
For further information, please contact:
Destiny Pharma plc
Neil Clark, CEO
Simon Sacerdoti, CFO
pressoffice@destinypharma.com
+44 (0)1273 704 440
FTI Consulting
Simon Conway / Victoria Foster Mitchell
destinypharma@fticonsulting.com
+44 (0) 20 3727 1000
Cantor Fitzgerald Europe (Nominated Adviser and Joint
Broker)
Philip Davies / Will Goode, Corporate Finance
Andrew Keith, Healthcare Equity Sales
+44 (0)20 7894 7000
finnCap Ltd (Joint Broker)
Geoff Nash /Kate Bannatyne, Corporate Finance
Alice Lane, Corporate Broking
+44 (0)20 7220 0500
About Destiny Pharma
Destiny Pharma is an established, clinical stage, innovative
biotechnology company focused on the development of novel medicines
that represent a new approach to the treatment of infectious
disease. These potential new medicines are being developed to
address the need for new drugs for the prevention and treatment of
life-threatening infections caused by antibiotic-resistant
bacteria, often referred to as "superbugs". Tackling anti-microbial
resistance has become a global imperative recognised by the World
Health Organisation (WHO) and the United Nations, as well as the G7
and the G20 countries. For further information, please visit
https://www.destinypharma.com
This information is provided by RNS
The company news service from the London Stock Exchange
END
MSCILMMTMBABBAP
(END) Dow Jones Newswires
April 23, 2018 02:00 ET (06:00 GMT)
Destiny Pharma (LSE:DEST)
Historical Stock Chart
From Apr 2024 to May 2024
Destiny Pharma (LSE:DEST)
Historical Stock Chart
From May 2023 to May 2024